GERN Q4 2018 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$375,000+96.3% YoY

Gross Profit

-$4M-985.1% margin

Operating Income

-$10M-2557.1% margin

Net Income

-$7M-1946.7% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

+127.3%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$185M

Total Liabilities

$8M

Stockholders' Equity

$178M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$375,000	$191,000	+96.3%
Gross Profit	-$4M	-$2M	-107.6%
Operating Income	-$10M	-$8M	-23.2%
Net Income	-$7M	-$7M	+1.7%